Authors: Sachetelli, S Khalil, H Chen, T Beaulac, C Senechal, S Lagace, J

Citation: S. Sachetelli et al., Demonstration of a fusion mechanism between a fluid bactericidal liposomalformulation and bacterial cells, BBA-BIOMEMB, 1463(2), 2000, pp. 254-266

Authors: Beaulac, C Sachetelli, S Lagace, J

Citation: C. Beaulac et al., Aerosolization of low phase transition temperature liposomal tobramycin asa dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa, J DRUG TAR, 7(1), 1999, pp. 33-41

Authors: Beaulac, C Sachetelli, S Lagace, J

Citation: C. Beaulac et al., In vitro bactericidal evaluation of a low phase transition temperature liposomal tobramycin formulation as a dry powder preparation against gram negative and gram positive bacteria, J LIPOS RES, 9(3), 1999, pp. 301-312

Authors: Sachetelli, S Beaulac, C Riffon, R Lagace, J

Citation: S. Sachetelli et al., Evaluation of the pulmonary and systemic immunogenicity of Fluidosomes, a fluid liposomal-tobramycin formulation for the treatment of chronic infections in lungs, BBA-GEN SUB, 1428(2-3), 1999, pp. 334-340